Year |
Citation |
Score |
2024 |
Li X, Zhang CC, Lin XT, Zhang J, Zhang YJ, Yu HQ, Liu ZY, Gong Y, Zhang LD, Xie CM. Elevated expression of WSB2 degrades p53 and activates the IGFBP3-AKT-mTOR-dependent pathway to drive hepatocellular carcinoma. Experimental & Molecular Medicine. PMID 38177295 DOI: 10.1038/s12276-023-01142-6 |
0.301 |
|
2023 |
Lu F, Gao J, Luo Y, Jin WL, Wang H, Li CX, Li X. CircCPSF6 promotes hepatocellular carcinoma cancer progression by regulating MAP4K4 through sponging miR-145-5p. Molecular and Cellular Probes. 101920. PMID 37442529 DOI: 10.1016/j.mcp.2023.101920 |
0.338 |
|
2022 |
Liu S, Zhang H, Yan J, Zhu J, Bai Z, Li X. FOXP3 and SQSTM1/P62 correlate with prognosis and immune infiltration in hepatocellular carcinoma. Pathology, Research and Practice. 242: 154292. PMID 36630868 DOI: 10.1016/j.prp.2022.154292 |
0.366 |
|
2015 |
Zhou SL, Zhou ZJ, Hu ZQ, Li X, Huang XW, Wang Z, Fan J, Dai Z, Zhou J. CXCR2/CXCL5 axis contributes to epithelial-mesenchymal transition of HCC cells through activating PI3K/Akt/GSK-3β/Snail signaling. Cancer Letters. 358: 124-35. PMID 25462858 DOI: 10.1016/J.Canlet.2014.11.044 |
0.314 |
|
2014 |
Chia CS, Ong WS, Li XJ, Soong YL, Chong FT, Tan HK, Soo KC, Qian CN, Teh BT, Iyer NG. Serglycin expression: An independent marker of distant metastases in nasopharyngeal carcinoma. Head & Neck. PMID 24995621 DOI: 10.1002/hed.23841 |
0.356 |
|
Show low-probability matches. |